Literature DB >> 6849621

Do the mentally retarded suffer from affective illness?

R Sovner, A D Hurley.   

Abstract

Twenty-five published reports were reviewed regarding the occurrence of affective illness, ie, depression and mania, in mentally retarded individuals, using the DSM-III criteria to assess the validity of both diagnoses. Individuals with mental retardation (MR) were found to manifest the full range of affective disorders. Developmentally impaired social functioning and intelligence influence the clinical presentation, but not the development, of affective symptomatology. Affective disorder diagnoses can be made for patients with all levels of MR severity. In individuals with MR of mild and moderate severity, the diagnosis can be made using standard DSM-III criteria. For those with severe and profound MR, a clinically useful diagnosis can be based on changes in behavior and vegetative functioning, as well as family history of affective illness. The psychiatrically symptomatic person with MR should always be evaluated for affective symptomatology and be considered as a candidate for the full range of treatments, including psychotherapy and pharmacotherapy with antidepressants as well as lithium carbonate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849621     DOI: 10.1001/archpsyc.1983.01790010063008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

Review 1.  Comorbidity in pediatric bipolar disorder.

Authors:  Gagan Joshi; Timothy Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

2.  Mood and Anxiety Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression.

Authors:  Lauren Charlot; Curtis K Deutsch; Aranya Albert; Anne Hunt; Daniel F Connor; William J McIlvane
Journal:  J Ment Health Res Intellect Disabil       Date:  2008

3.  Validity of the PAS-ADD for detecting psychiatric symptoms in adults with learning disability (mental retardation).

Authors:  S Moss; B Ibbotson; H Prosser; D Goldberg; P Patel; N Simpson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-08       Impact factor: 4.328

4.  Preliminary study of imipramine in profoundly retarded residents.

Authors:  M G Aman; A J White; C Vaithianathan; C J Teehan
Journal:  J Autism Dev Disord       Date:  1986-09

5.  Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome.

Authors:  Ovsanna T Leyfer; Janet Woodruff-Borden; Bonita P Klein-Tasman; Johanna S Fricke; Carolyn B Mervis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-09-05       Impact factor: 3.568

6.  Comorbidity of autistic disorder in children and adolescents.

Authors:  Mohammad Ghaziuddin; L Tsai; N Ghaziuddin
Journal:  Eur Child Adolesc Psychiatry       Date:  1992-10       Impact factor: 4.785

7.  Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder.

Authors:  Gagan Joshi; Joseph Biederman; Janet Wozniak; Robert Doyle; Paul Hammerness; Maribel Galdo; Nora Sullivan; Courtney Williams; Kristin Brethel; K Yvonne Woodworth; Eric Mick
Journal:  CNS Neurosci Ther       Date:  2010-11-29       Impact factor: 5.243

8.  Mental health assessed by the Strengths and Difficulties Questionnaire for children born extremely preterm without severe disabilities at 11 years of age: a Norwegian, national population-based study.

Authors:  Silje Katrine Elgen Fevang; Mari Hysing; Kristian Sommerfelt; Irene Elgen
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-06-05       Impact factor: 4.785

9.  Anxiety disorders in children with williams syndrome, their mothers, and their siblings: implications for the etiology of anxiety disorders.

Authors:  Ovsanna Leyfer; Janet Woodruff-Borden; Carolyn B Mervis
Journal:  J Neurodev Disord       Date:  2009-03       Impact factor: 4.025

10.  Issues in the treatment of mentally retarded patients in the community mental health system.

Authors:  F J Menolascino; S F Gilson; A S Levitas
Journal:  Community Ment Health J       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.